Klaus Elenius
Has grant
professor of medical biochemistry
FinlandResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Klaus Elenius is a professor of medical biochemistry at the University of Turku, Finland. His research primarily focuses on signaling pathways related to cancer, as reflected in his recent publications on ErbB inhibitors, oral tongue squamous cell carcinoma, and the SUMO pathway. Professor Elenius has contributed significantly to understanding trans-activating mutations in ERBB3 and the role of STAT5b in myocardial growth, among other pivotal studies in the field.
Recent Grants
Grant: Close
Predictive biomarkers for ERBB-targeted cancer drugs
Open Date: 2018-01-09
Close Date: 2022-12-31
Grant: Close
Regulated Intramembrane Proteolysis in Receptor Tyrosine Kinase-driven Tumor Growth
Open Date: 2014-01-09
Close Date: 2018-08-31
Grant: Close
Novel Signaling Mechanisms of ErbB Receptors in Cancer
Open Date: 2011-01-01
Close Date: 2014-12-31
Grant: Close
Oncogenic Potential of ErbB4 Receptor Isoforms
Open Date: 2007-01-01
Close Date: 2010-12-31
Grant: Close
Oncogenic Potential of erbB4 Reseptor Isoforms
Open Date: 2004-01-08
Close Date: 2007-12-31
Articles (8)
Year:
2025
Year:
2025
Year:
2024
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Collaborators (13)
Maria Sundvall
University of Turku
Johanna Ivaska
Professor at University of Turku
University of Turku
Lea Sistonen
Åbo Akademi University
Aarno Palotie
University of Helsinki
Elmo Saarentaus
University of Helsinki
Anne Jokilammi
University lecturer
University of Turku
Kari Alitalo
University of Helsinki
Kari Salokas
University of Helsinki
Karthik Amudhala Hemanthakumar
University of Helsinki
Noora Virtanen
Åbo Akademi University
Ilkka Paatero
-
Pekka Taimen
-
Riikka Kivelä
University of Helsinki
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.